Previous Article | Next Article 
J Virol, April 1998, p. 3117-3128, Vol. 72, No. 4
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
The Activity of Sendai Virus Genomic and
Antigenomic Promoters Requires a Second Element Past the Leader
Template Regions: a Motif (GNNNNN)3 Is Essential for
Replication
Caroline
Tapparel,
Diane
Maurice, and
Laurent
Roux*
Department of Genetics and Microbiology,
University of Geneva Medical School, Centre Medical Universitaire,
1211 Geneva 4, Switzerland
Received 10 November 1997/Accepted 23 December 1997
 |
ABSTRACT |
The paramyxovirus genome, a nonsegmented, negative-polarity,
single-stranded RNA of ~15 kb, contains six transcription units flanked at the 3' and 5' ends by a short (~ 50- to 60-nucleotide) extracistronic sequence, dubbed the positive and negative leader regions. These leader template regions, present at the 3' end of the
genome and the antigenome, have been shown to contain essential signals
governing RNA replication activity. Whether they are sufficient to
promote replication is still open to question. By using a series of
Sendai virus defective interfering RNAs carrying a nested set of
deletions in the promoter regions, it is shown here that for both the
genomic and antigenomic promoters, a 3'-end RNA sequence of 96 nucleotides is required to allow replication. Sequence comparison of
active and inactive promoters led to the identification of a set of
three nucleotide hexamers (nucleotides 79 to 84, 85 to 90, and 91 to
96) containing a repeated motif RXXYXX [shown as 5'-3'
positive-strand]. Sequential mutation of each hexamer into its
complementary sequence confirmed their essential role. The three
hexamers are required, and their relative positioning is important,
since displacing them by 6 nucleotides destroyed promoter function.
RNAs carrying degenerate nucleotides in the three hexamers were used as
replication templates. They led to the selection of actively
replicating RNA species exclusively carrying the basic motif
(GNNNNN)3 from nucleotides 79 to 96. These results clearly show that, apart from the region from nucleotides 1 to 31, previously identified as governing Sendai virus replication activity, a second element, spanning at the most nucleotides 79 to 96, appears essential. Thus, the paramyxovirus replication promoters are not confined to the
leader template regions, as seems to be the case for the rhabdoviruses.
 |
INTRODUCTION |
The genome of viruses belonging to
the Paramyxovirinae subfamily is a nonsegmented
single-stranded RNA (~15 kb) of negative polarity, tightly assembled
with more than 2,600 subunits of the nucleocapsid protein in a linear
structure of helicoidal symmetry. The nucleocapsid is the biologically
active viral genome. In general, it contains six transcription units,
flanked at the 3' and 5' ends by two short extracistronic sequences,
dubbed the positive and negative leader regions (the latter is also
called the trailer region). During replication, the viral RNA is copied
into its full complement, the antigenome, which is also in the form of a nucleocapsid. The leader template regions present at the 3' end of
the genome and the antigenome RNAs are known to contain essential
signals governing genome replication and so represent genome and
antigenome promoters for RNA replication. It is noteworthy that the
promoter in the present context refers not only to the 3'-end
nucleotides of the template RNA but also to the 5'-end nucleotides of
the nascent RNA. This because the encapsidation efficiency of this
nascent RNA is also a factor which governs replication (for a general
review on paramyxovirus replication, see reference
30). The detailed participation of either RNA sequence still needs to be determined precisely, beyond the general assessment that the template 3' end must be involved in binding the
polymerase while the nascent RNA 5' end could control replication elongation through encapsidation efficiency.
Sendai virus (SeV), a member of the Paramyxovirus genus in
the Paramyxovirinae subfamily, matches these general
features. Its genome is 15,384 nucleotides (nt) long with the positive
and negative leaders containing 55 and 57 nt, respectively (see Fig. 1A). The six transcription units encode the six major structural proteins, from 3' to 5', the nucleocapsid protein (N), the
phosphoprotein (P), the matrix protein (M), the envelope proteins (F
and HN), and the large protein (L), and these genes represent the
minimal essential genes of this virus subfamily. In many
paramyxoviruses, the P gene codes for additional proteins from extra
transcription units or from alternative expression mechanisms
(30). The SeV P gene encodes as many as eight different
polypeptides via overlapping open reading frames, mRNA editing, leaky
ribosomal scanning, and a ribosomal shunt (11, 12, 24, 29).
Among these extra proteins, the C proteins are a nested set of four
polypeptides (called C', C, Y1, and Y2), initiated at different
translation start sites (in the 1+ frame relative to P) but having a
common C-terminal end. These accessory C proteins have recently been shown to act on the replicating complex by increasing its selectivity for signals governing its function (43).
SeV, in common with many viruses (for a review, see reference
22), very readily produces deleted versions of the
genome during rapid multiplication. These can be amplified by the
replication complex expressed by the nondeleted (ND) genome, and since
they replicate better than the ND genome, they are referred to as
defective interfering (DI) RNAs. These molecules have been valuable in
the development of reverse genetics of the negative-stranded RNA
viruses. Due to their small size, they were the first viral RNA
templates to be successfully replicated when they were transcribed from DNA plasmids in a system in which the replicating complex (the L, P,
and N proteins) was itself expressed from plasmids (for a review, see
reference 9). Two DI RNAs have been instrumental in
the study of SeV. The first is an internal deletion DI RNA (see Fig.
1B) (DI-E307), which retained the ND RNA ends (i.e., the genomic [GP]
and antigenomic [AGP] promoters). E307, as expected from its primary
structure, was shown to have retained its transcription potential
(18). The second is a copy-back DI RNA (DI-H4), which lacks
transcription potential through the loss of the genomic promoter. This
is replaced by 110 nt identical to those present at the plus-strand 3'
end, so that DI-H4 contains antigenomic promoters on both the minus
(AGPL) and the plus (AGPR) strands (see Fig.
1C) (4). When the two RNAs were compared, DI-H4 was found to
replicate 20-fold better than E307 (6). Since the two RNAs
have different promoters at the minus-strand 3' end, this difference in
replication was postulated to be due to the possession of the stronger
AGP promoter on both the positive and negative-strands of DI-H4.
Experiments involving reciprocal sequence exchanges between the two
promoters supported this conclusion, since there was a direct
correlation between the amount of either promoter present and the
replication ability of the chimeric RNAs: the larger the AGP sequence,
the greater the replication and vice versa (6). In a further
study, it was shown that the first 31 nt of AGP are responsible for the
high replication property (10- to 20-fold) (44). Other
features of the promoters were unravelled by using these RNA
derivatives, including the absence of an interference of transcription
on the replication ability (interference that could have explained the
lower replication ability of a transcribing DI RNA
[6]) and the lack of influence of the extent of RNA
terminal complementarity (44), which had been postulated to
positively influence replication (47).
The reciprocal sequence exchanges made to create these RNA derivatives
resulted in the juxtaposition of sequence from each promoter, making it
difficult to dissect the relative contributions of the components of
the "hybrid" promoters to their activity. In fact, the preparation
of derivatives with exact reciprocal exchanges required this
complementation between promoter components. Therefore, this approach
did not provide firm information about the minimal sequence length
required for an active replication promoter. This minimal length was
originally predicted to be that of the leader template regions, since
these do not participate in the coding capacity. This prediction was
recently verified for vesicular stomatitis virus (VSV), a virus of the
Rhabdoviridae family having many features in common with the
Paramyxoviridae (32). In the case of the
paramyxoviruses, this question is still open, and there are some
indications that the paramyxoviruses may differ in that respect from
the rhabdoviruses. First, the primary structure of the naturally
obtained defective RNAs shows that the shortest end sequence remnant of
the nondefective genome is 94 nt (i.e., extending past the leader
regions), with a range between 94 and 168 nt (4, 17, 31, 37,
41). This contrasts with VSV, for which at least one copy-back DI
RNA has been shown to contain only the negative leader template region
(45 nucleotides [38]), with a range varying between 45 and 150 nt (22). Second, a sequence homology between the
first 3'-end nucleotides of SeV and a stretch of 15 to 20 nt further
inward than the leader template region (nt 75 through 90) led to the
speculation that these nucleotides could be part of the promoter (BB3
box [1, 10]). Third, in addition to the demonstration
that AGP nt 1 to 31 confer high replication efficiency in SeV, a second
region, broadly defined as extending from nt 48 to 98 (i.e., extending
past the leader template region) was found to participate in the
modulation of replication efficiency (44). Fourth, the
inhibition of replication resulting from an 18- or 12-nt insertion
between nt 47 and 67 of GP of an E307 derivative was interpreted as the
forbidden displacement of a putative promoter element located
downstream of nt 67 (36). These results were supported by a
recent study, in which a 6-nt insertion at this position was found to
obliterate replication under defined conditions (43).
Finally, it may be significant that all the artificial paramyxovirus
minigenomes that were created and reported to successfully replicate
when expressed from DNA plasmids contained promoters of more than 100 nucleotides (7, 8, 15, 42, 48).
The present study shows that the minimal length of the genomic and
antigenomic promoters of SeV extends past the leader template regions
to nt 91, at the least. A motif, consisting of
5'-G79(N)5-G85(N)5-G91(N)5-3'
(shown as plus-strand DNA) is identified, and its position cannot be
displaced by 6 nt to either side. This identification was made by
site-directed mutagenesis and by sequence analysis of RNAs selected by
efficient replication from a pool of template RNAs containing
degenerate nucleotides at these critical positions.
 |
MATERIALS AND METHODS |
Virus and cells.
Cells (A549 and HeLa) were grown under a
5% CO2 atmosphere in regular minimal essential medium
(MEM) supplemented with 5% fetal calf serum. Recombinant vaccinia
virus expressing the T7 RNA polymerase, vTF7-3, a gift from Bernard
Moss (National Institutes of Health, Bethesda, Md.) was described by
Fuerst et al. (20) and used as specified. vTF7-3 stocks were
grown in HeLa cells with titers ranging from 5 × 108
to 1 × 109 PFU/ml.
Sequence and plasmids.
The complete SeV RNA primary sequence
(15,384 nt) is taken from the work of Shioda et al. (39, 40)
and Neubert et al. (35). The sequence is written as DNA
according to standard convention, 5' to 3' from left to right. The
plasmids expressing SeV N (pGem-N), P plus C (pGem-P/C, here referred
to as PCwt), and L (pGem-L) under the control of the T7 RNA
polymerase promoter have been described previously (11, 14, 23,
24).
The structures of the SeV DI-H4 and E307 RNAs are presented in Fig.
1B and C, in relation
to the nondefective RNA (Fig. 1A). The cloning of these DI RNAs in
pSP65 (respectively pSV-DI-H4 and pSV-E307) under the control of the T7
RNA polymerase promoter has been described previously (4, 6,
18), and a schematic representation of pSV-DI-H4 is shown in Fig.
1D. As before (6, 44), the 3' end of the viral genome is
called the genomic promoter (GP) and the 3' end of the antigenome is
called the antigenomic promoter (AGP). In the case of H4 RNA, which
contains the AGP on both the minus- and plus-strand RNA, the
distinction between the two promoters is made by using AGPL
(left) or AGPR (right). In all the derivatives used in this
study, only the 3' end of the H4 positive- strand RNA
(AGPR) has been modified. H4-AGP(+)57 was obtained by
replacing the DraIII-BamHI fragment pSV-DI-H4
(see Fig. 2) with that of H4-AGP(
/+)57 (44). The DI-H4s of
the
Dra/GP series (see Fig. 3 and 4) were constructed by replacement
of the same H4 DraIII-BamHI fragment with
DraIII-BamHI fragments obtained by PCR
amplification from either H4-AGP(
)120/(+)98 (44) or
H4-AGP(
/+)57 with DraIII carrying oligonucleotides
adjusted to match the deletions and Rib3 as amplimers (see Fig. 2). The
DI-H4s of the
Dra/AGP series carrying deletions (see Fig. 3 and 6),
site-directed mutations (see Fig. 5), or degenerate positions (see Fig.
7 and 8) were constructed by replacement of the H4
DraIII-BamHI fragment with a PCR product obtained
with primer Rib3 and the corresponding primer spanning the
DraIII site carrying the appropriate sequence, with pSV-E307
as the template (see Fig. 2, lower part, where only the primers for the
degenerate positions are shown). For H4-AGP(+)57 (see Fig. 3), in which
the first 57 nt of the H4 plus-strand 3' end (AGPR) was
replaced by 57 nt from E307 GP, the previously used nomenclature applies (detailed in reference 44). For all the
other H4 derivatives, a description of their structure is shown in the
figures, along with their names. It is noteworthy that all the
derivatives used in this study contain a total number of nucleotides
that is a multiple of 6 to comply with the rule of six (5).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 1.
SeV RNAs and template plasmid structure. (A) The SeV
genome (negative-strand RNA of 15,384 nt) is presented 3' to 5' as a
grey rod, with the main transcription units indicated (not to scale).
At each end, le+ and le
refer to the extracistronic regions, with the promoter for antigenome
synthesis indicated (GP). The DraIII site, central to this
study, is shown. Above, the transcription products include the
le+ RNA and the six mRNAs, whose synthesis
sequentially proceeds from the same GP region. Below, the antigenome is
schematized exactly complementary to the full-length genome, with the
AGP at its 3' end. (B) The structure of the internal deletion DI RNA
E307 is shown as negative and positive strands to emphasize the remnant
GP and AGP promoter sequences, as in the SeV genome. A deletion from nt
607 to 14197 results in the fusion of the N and L genes, so that
transcription produces on top of the le+ RNA a
fused N/L mRNA. The E307 sequence is used in this study only as the
donor of GP sequences. (C) The copy-back DI-H4 RNA structure emphasizes
the presence, at the negative- strand 3' end, of the same promoter
sequence region (110 nt, nt 15275 to 15384) as that of the
positive-strand 3' end. Both strands contain in this way the same
promoter, named AGPL and AGPR, respectively. No
mRNA is transcribed from DI RNA. The box in the middle of the sequence
scheme is there to specify the backbone sequence of the viral RNA,
i.e., L sequence only for H4, N and L sequences for E307 (see panel B).
Numbering for panels B and C corresponds to that of the full-length
genome in panel A. (D) The H4 sequence is shown in the pSP65
plasmid, where it has been cloned along with the T7 promoter sequence.
T7 transcription, which starts at the exact viral RNA 5' end, produces
an exact positive-strand DI RNA through endolytic cleavage at the 3'
end by the hepatitis delta virus ribozyme. Relevant restriction sites and
positions are indicated. The numbering has been adjusted here to the H4
sequence inserted in plasmid pSP65.
|
|
Replication system and recovery of the encapsidated RNA.
The
replication system used has been described previously (6).
It has been used here with changes in the procedure of replicated RNA
recovery. In brief, A549 cells (about 107) were infected
with vTF7-3 (multiplicity of infection, 3). At 1 h later, the
cells were transfected with 5 µg of pGem-N, 5 µg of
pGem-PCwt, 1.5 µg of pGem-L, or 5 µg of the plasmid
carrying the DI-RNA sequence, by incubation of the cells (3 h at
33°C) with 3 ml of MEM containing the plasmid mixture and 15 µl of
Transfectace (Gibco BRL). Then 7 ml of MEM-5% fetal calf serum was
added. At 40 h later, the cells were disrupted in 500 µl of
lysis buffer (0.6% Nonidet P-40, 20 mM Tris-HCl
[pH 8.0], 10 mM NaCl) and the clarified cytoplasmic extracts
(3,000 × g for 15 min at 4°C) supplemented with 300 µl of TE (10 mM Tris-HCl [pH 7.5], 1 mM EDTA) containing 3 mM
CaCl2 were incubated with 2.5 µg of micrococcal nuclease (Biofinex) for 15 min at 37°C. After nuclease inactivation by addition of 20 mM EDTA and 4 mM EGTA (final concentrations),
encapsidated RNA, resistant to nuclease digestion, was treated with
proteinase K (1 µg/µl for 10 min at 55°C; Boehringer Mannheim) in
the presence of 1% Sarkosyl. After chloroform-phenol extraction, the
RNA was separated from residual DNA by pelleting it through a 5.7 M
CsCl cushion (12 h at 32,000 rpm in a Beckman SW55 at 12°C) and
resuspended in TE buffer.
Analysis of the encapsidated RNA.
One-fifth of the
replicated RNA was analyzed by Northern blotting with an RNA probe of
the same polarity as the T7 DI RNA transcript (plus strand) to detect
the minus-strand RNA resulting from replication (6, 43, 44).
When required, the remaining four-fifths of the RNA was used to reverse
transcribe a 5'-end portion of the minus-strand RNA (extremity
complementary to the end carrying the AGPR sequence) with
Moloney murine leukemia virus reverse transcriptase (Promega) as
specified by the manufacturer, with 100 U of enzyme in a 50-µl
reaction mixture (60 min at 42°C with primer RT [Fig. 2]). One-tenth of this reaction mixture
was then PCR amplified with Taq DNA polymerase (Gibco BRL)
as specified by the manufacturer (100-µl reaction mixture subjected
to 25 cycles with RT and PCR primers [Fig. 2]). After purification on
columns (QIAquick PCR purification kit [Qiagen]), two-thirds of the
PCR product was sequenced with a LiCor automated sequencing device
(MWG-Biotech AG) as specified by the manufacturer (with the IRD primer
[Fig. 2]). When not directly sequenced, the RT-PCR product was
subcloned into the DraIII and BamHI sites of
pSV-DI-H4 plasmid to be sequenced as individual clones.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 2.
Primers. The primers (RT and PCR), used for the RT-PCR
amplification of a fragment covering the AGPR region of DI
RNA derivatives in verification of the selection experiment results
(see Fig. 7 and 8), are shown below the schematized H4 sequence, along
with the IRD primer used for the sequencing. Below the
H4-(+) Dra/AGP96 schematized sequence, the series of oligonucleotides
used to construct the plasmids containing the degenerate nucleotides
are outlined, with Rib3 commonly used. Numbering refers to positions in
the pSV-DI-H4 plasmid (Fig. 1D).
|
|
 |
RESULTS |
The SeV promoters extend past the leader template regions.
The
copy-back DI-H4 RNA (Fig. 1C) was used as the backbone for all the RNA
template derivatives tested for replication in this study. The
replication system was identical to that used previously (5, 6,
43, 44). Cells in culture were transfected with a series of four
plasmids carrying genes encoding, for three of them, the functions
required for encapsidation of the RNA template (protein N) and for
replication (proteins P and L). The pGem-P plasmid (PCwt)
also expresses the four accessory C proteins (13). The
fourth plasmid expresses the template RNA (as plus-strand RNA) from the exact 5' to the exact 3' viral nucleotides (Fig. 1D). The four plasmids
were transcribed by T7 RNA polymerase expressed from the recombinant
vaccinia virus, vTF7-3, infecting the transfected cells. The replicated
RNAs were purified as a nuclease-resistant fraction, and the extent of
replication was monitored by Northern blotting with an RNA probe of
positive polarity to score the RNA complementary to the template RNA
produced by the T7 polymerase. Dependence on the SeV RNA polymerase was
controlled by omitting the P protein (or P and L).
In a previous study, a reciprocal exchange between E307 and H4 RNAs had
produced an H4 RNA derivative in which AGP
R had been
replaced with the first 57 GP nucleotides [H4-AGP(+)57
(Fig.
3; the figure legend gives the
nomenclature of the RNA derivatives)].
Out of its natural context, the
57 GP nucleotides allowed H4-AGP(+)57
to replicate (
44).
Such a construct, however, could not be used
to assess the minimal
length of GP, since it is difficult to rule
out the participation of
the adjacent AGP sequence (from nucleotide
58 inward) in creating the
active promoter. To avoid a possible
complementation with AGP
sequences, GP sequences had to be fused
to the H4 plus strand
sufficiently far from the 3' end. A
DraIII
site, located 171 nt from the AGP
R extremity (in the 3'-end open reading
frame [ORF] of the L gene,
~30 nt before the stop codon), was then
chosen to generate H4
derivatives with various GP sequence lengths
incorporated at AGP
R (Fig.
3, H4-

DRA/GP series). This
location was considered sufficiently
remote from the end
because numerous natural paramyxovirus copy-back
DI RNAs replicate
efficiently with the minus-strand promoter (inverted
repeat,
AGP
L [Fig.
1C]) close to 100 nt long (e.g., 110 nt in SeV
DI-H4 [see
also Introduction]), indicating that the promoter sequence
is
unlikely to extend past this limit. In the H4-

DRA/GP series,
the
GP 119 nt (H4-

DRA/GP119) correspond to the sequence at the
genome 3'
end extending to the start codon of the first transcription
unit, the N
gene. H4-

DRA/GP54, on the other hand, contains just
the leader
positive template region. The derivatives in between
contain increasing
amount of sequence (78 to 102 nt) all ending
in the 5' noncoding region
of the N gene. Figure
3 shows the replication
ability of these RNAs.
This has to be compared with the P (

)
assay, which represents the
negative control. Replication of derivatives
H4-

DRA/GP119 to
H4-

DRA/GP96 was clearly positive (P+ lanes),
while for
H4-

DRA/GP90 to 54, no signal over the background was
detected.
Positive replication reached a much lower level than
that of H4 RNA,
consistent with the replacement of the strong
AGP promoter with
sequence derived from the weak GP promoter (
6).
A
DraIII-
ScaI fragment (containing the GP sequence,
the ribozyme,
and part of the vector plasmid [Fig.
1D]) was excised
from the
H4-

DRA/GP90 and H4-

DRA/GP54 plasmids (expressing
nonreplicating
RNAs) and replaced with the same fragment derived from
the original
pSV-DI-H4 to re-create an integer H4-RNA. This was found
to replicate
at the H4 level (data not shown), excluding the
possibility that
an unexpected modification had occurred in the region
that had
not been deliberately modified (and therefore not sequenced)
during
construction of the derivative. All the RNA transcripts of the
H4-

DRA/GP series contained the same 5' end, making it unlikely
that
lower encapsidation ability of some of the T7 RNA transcripts
could
account for the differences in replication observed. A Northern
blot
analysis of the encapsidated T7 RNA transcripts produced
in a P and L
(

) assay, using a minus-strand RNA probe, confirmed
the equivalence
of encapsidation of all the derivative RNAs (data
not shown). When the
replication of the functional H4-

DRA/GP
RNAs (RNAs 119, 102, and 96)
is compared to that of H4-AGP(+)57,
it is noteworthy that the former
RNAs replicated on average 10-fold
less efficiently. If all four
constructs share the first 57 GP
nucleotides, the H4-AGP(+)57 sequence
then diverges into the AGP
sequence. The implication of these facts
will be addressed in
Discussion.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 3.
Minimal genomic promoter length. The H4- Dra/GP series
(obtained as described in Materials and Methods) in which various GP
lengths have been fused to the DraIII site, replacing the
original AGPR sequence, are shown with (from top to bottom)
decreasing lengths of the GP sequence. The promoter on the 3' end of
the H4 negative strand (AGPL) is the same for all the
derivatives. H4-AGP(+)57 is particular in that the GP 57 nt exactly
replaces the AGPR 57 nt, introducing an
le+ template region in place of
le one. E307 RNA is shown for general DI RNA
structure information and because it is the original source of the GP
sequences. To the right-hand side, a Northern blot analysis of the
encapsidated viral RNAs recovered from in vivo replication assays (see
Materials and Methods) primed with the RNAs described to the left is
shown. The P + or lanes refer, respectively, to fully
competent replicating assays and to assays done in the absence of the P
protein as negative controls. The RNA probe (5' ex) (44) is
of positive polarity to score the RNA species complementary to the T7
RNA transcript.
|
|
Similar derivatives were constructed with AGP sequences of various
lengths fused to the
DraIII site (Fig.
4A, H4-

DRA/AGP
series). Replication
was observed with 102 and 96 AGP nt but not
with 90 nt (Fig.
4B). It is
noteworthy that positive replication
reached the level of H4,
confirming that none of the sequence
deleted between nt 97 and the
DraIII site (nt 170) is required.
In conclusion, for both GP
and AGP, the replication promoter is
shown to extend past the leader
template regions down to nt 96
at the most.

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 4.
Minimal AGP length. (A) As in Fig. 3, except that the
proper AGPR region of DI-H4 RNA has been increasingly
truncated from the DraIII site position toward the
plus-strand 3' end, leaving the number of nucleotides indicated in the
denomination of the derivatives (102, 96, and 90 nt). The numbers to
the right refer to the total number of nucleotides in the RNA. (B)
Northern blot as in Fig. 3, with the RNA derivatives with AGP
truncations shown in panel A.
|
|
Three hexamers of importance for effective replication.
Examination of the sequences beyond the leader template regions
highlighted a similarity in the region spanning nt 75 to 90 (1,
10). An alignment of the AGP and GP sequences in that region
revealed a possible G1NNYNN6 motif repeated
three times between nt 79 and 96 (36). The alignment was
done by comparing blocks of 6 nt (hexamers), based on the rationale
that the template RNA is likely to be seen by the RNA polymerase in
this context. This conclusion was drawn from data suggesting (i) that
each N protein subunit covers exactly 6 nt (5, 16) and (ii)
that the six contact points of the N subunit with the 6 nt are not
equivalent (36). The phase context of each nucleotide was
then postulated to be an important feature of the signals recognized by
the replicating (transcribing?) complex (28, 36). A limited
comparison with other GP promoters (generated for other purposes, some
of which are reported by Mottet et al. [33]),
competent or not competent for replication, appeared to support the
presence of a purine in position 1 of each hexamer, so that the
postulated conserved motif can be better written
R1NNYNN6, with a preference for G in position 1 (Fig. 5A). The presence of this motif
would argue for the importance of the three hexamers 14 (nt 79 to 84),
15 (nt 85 to 90), and 16 (nt 91 to 96) in defining the active promoter.

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 5.
Importance of the postulated motif in hexamers 14, 15, and 16. (A) SeV AGP and GP are aligned (as positive-strand DNA from 5'
to 3') in groups of 6 nt (hexamers), to emphasise a sequence similarity
repeated in the three hexamers 14, 15, and 16. The four sequences
presented below the AGP and GP sequences originate from modified
versions of GP, which led to successful (competent Yes) or unsuccessful
(competent No) replication (reference 33 and
unpublished data). The postulated motif is the nucleotide sequence
predicted to be required for competent replication in the three
hexamers. (B) H4(+) Dra/AGP96 derivatives carrying, in
AGPR, substitutions introduced at positions marked with an
asterisk. Every mutation consists of the replacement of a nucleotide(s)
by its (their) complement(s). Yes and No refer to the ability of these
RNA derivatives to be replicated, as shown in panel C. (C) Northern
blot analysis of the encapsidated RNAs described in panel B recovered
from replication assays as described in the legend to Fig. 3.
|
|
A series of derivatives of H4-

DRA/AGP96, the one carrying the
shortest AGP active promoter, was then produced in an attempt
to verify
the requirement for these hexamers and eventually the
importance of the
motif they contain. First, each hexamer was
serially converted into its
complement sequence (Fig.
5B, constructs
4, 5, and 6), with hexamer 13, not predicted to contain a particularly
required sequence, taken as a
control (construct 7). The absence
of replication of the first three,
in contrast to the quasinormal
replication ability of the latter (Fig.
5C), pointed to the importance
of the wild-type sequence in each of the
three hexamers. It also
indicated that three hexamers are required
together since two
hexamers remained in each of the nonreplicating
constructs. The
requirement for the three hexamers was further
confirmed by the
absence of replication of derivatives in which hexamer
15 or 14
had been deleted, leaving two adjacent hexamers with wild-type
sequence (Fig.
6B and C, constructs 2 and
3). Note, in Fig.
6,
that the deletion of hexamer 13 (construct 4),
shown not to be
important in itself, abolished replication.
Interestingly, this
shows that it is not enough for the three hexamers
to be present
and integer; they also cannot be displaced by 6 nt toward
the
template 3' end (see Discussion).

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 6.
The three hexamers are required for competent
replication. (A) H4(+) Dra/AGP96 derivatives carrying, in
AGPR, deletions of one hexamer as indicated. (B) Outline of
the relevant sequence in the derivatives schematically presented in
panel A. Note that in derivatives 2 and 3, the sequence in hexamer 14 is different. In derivative 4, the three hexamers are present but
displaced toward the end (left) by 6 nt. (C) Replication ability of the
RNAs presented in panels A and B measured by Northern blot analysis, as
in Fig. 3C. For derivative 1, the result is shown in triplicate.
|
|
The motif is rather simple.
In a preliminary attempt to test
the validity of the motif, the G1 or the G1 and
T4 of hexamer 16 were changed into their complement
nucleotides (Fig. 5B and C, derivatives 2 and 3). The abolition of
replication by the single transversion in derivative 2 strongly
reinforced the possibility that the postulated motif could be
important. A more systematic verification of the importance of the
G1 in each hexamer was then undertaken as follows. Starting
with the plasmid carrying H4-(+)
DRA/AGP96, three new constructs were prepared with degenerate nucleotides (A, C, G, and T) replacing G1 of hexamers 14, 15, and 16 (nt 79, 85, and 91, respectively). In each new construct, another degenerate site was
created at position 1 of hexamer 13 (nt 73), a position predicted not
to be critical (Fig. 5, construct 7). Each plasmid preparation
(described as Selec 73/79, Selec 73/85, and Selec 73/91 [Fig.
7A]) contained a mixture of 16 different
sequences. After transfection, the encapsidated RNA which had
efficiently replicated was purified and the region spanning the
AGPR was amplified by RT-PCR, cloned, and sequenced to
determine the nucleotide present at the original degenerate positions.
Figure 7B shows that each plasmid preparation led to a significant
replication above the background. Figure 7C summarizes the sequencing
results. At position 73, the distribution of the nucleotides in the
RT-PCR products appeared to be random (with the limitation attached to the small number of clones sequenced), suggesting that replication can
take place with any nucleotide at this position. In contrast, an almost
absolute bias for G was observed in position 1 of hexamers 14, 15, and
16 in the RT-PCR products, a bias that the distribution in the original
clones cannot account for. Note that this bias for G79,
G85, or G91 was observed concomitant with the
absence of preference for any nucleotide at position 73, which served
as the internal control in each case. There appears, then, to be a
strong selection for the RNAs carrying a G at position 1 of each
hexamer.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 7.
Selection applied to the first nucleotide of each of the
three hexamers. Three oligonucleotides were created to contain two
degenerate positions; one common to all three at position 73, and the
other at position 79, 85, or 91, respectively, corresponding to the
first position of each of hexamers 14, 15, and 16 (see the outlined
sequence in panel B). PCR products, obtained with each of these three
degenerate oligonucleotides with, as the other amplimer, the Rib3
primer (Fig. 2), were cloned into the DraIII and
BamHI sites of H4(+) Dra/AGP96 to prepare the Selec 73/79,
Selec 73/85, and Selec 73/91 plasmids with modified AGPR
sequences. Pooled plasmid preparations were obtained from bacterial
colonies scraped from a large LA petri dish (diameter, 13 cm) plated
with 9/10 of a transformation reaction mixture; the remaining 1/10 was
plated to pick individual colonies, allowing the sequencing of
individual species (10 to 15 clones analyzed) to characterize the
starting pool of plasmids (Pre distribution in panel C). After
replication, using as the template plasmid each of the three pools, an
RT-PCR fragment covering the AGPR region was obtained and
cloned (see Materials and Methods) and 10 to 15 individual clones were
sequenced to characterize the nucleotide (Post) present at the original
degenerate position. (A) Schematized representation of the RNAs, with
the degenerate positions indicated by N. (B) Northern blot analysis of
the replicated encapsidated RNAs (as in Fig. 3), shown in duplicate for
H4(+) Dra/AGP96, Selec 73/79, and Selec 73/85. (C) Nucleotide
distribution at the positions of interest. The number accompanying the
nucleotide designation refers to the number of clones containing this
base at the indicated position. Pre, nucleotide distribution in the
original plasmid preparation; Post, nucleotide distribution in the
RT-PCR products after replication.
|
|
The analysis of the sequence requirement was extended in a similar
experiment in which all the six nucleotides in each hexamer
were
degenerate, creating the plasmid preparations Selec 14, Selec
15 and
Selec 16. The transfections were thus made with potentially
a mixture
of 4,096 different sequences (4
6). The sequence analysis of
either the initial plasmid preparations
and of the RT-PCR products
amplified from the replicated RNAs
(data not shown) was done this time
without cloning, for obvious
reasons. Figure
8 shows the printout image of the
sequences obtained
from the automatic sequencer. The results are
identical for the
three hexamers. Sequencing of the transfected plasmid
pools showed
a degenerate sequence of six nucleotides at the expected
positions.
After replication, the degenerate positions were still
observed
but were truncated by one nucleotide where, in all three
cases,
a C was now visible; these C's correspond to the G's of the
sequenced
plus-strand templates. The conclusions are twofold. First,
this
second selection experiment confirmed the bias for the presence
of
G at position 1 of each of the three hexamers. Second, they
ruled out
the strict requirement of any particular nucleotide
in the five other
positions, under the limitation of the selective
pressure applied here,
i.e., productive replication only.

View larger version (105K):
[in this window]
[in a new window]
|
FIG. 8.
Selection applied to the 6 nt of each of the three
hexamers. Three oligonucleotides were designed to contain six
degenerate positions corresponding to hexamers 14, 15, and 16. Pooled
plasmid preparations were obtained, as in Fig. 7. This time, Pre
sequence characterization was done by sequencing the pooled plasmid
preparation. After replication, RT-PCR products were obtained as in
Fig. 7, and Post sequence characterization was done by directly
sequencing the RT-PCR products of the replicated RNA. At the sides of
each sequence panel, the Pre and Post sequences are outlined. At the
bottom is shown the AGPR sequence from 5' to 3' (a) and the
sequence in the sequencing gel (complement of that in a) (b).
|
|
 |
DISCUSSION |
The first 31 nt of the SeV replication promoters have been
previously shown to represent an essential element, since they adjust
the efficiency of replication of the DI RNAs in the same replication
assay as that used here (6, 44). These promoters now extend
past the leader template regions, since, for genome as well as for
antigenome, they contain 96 nt at the most. A second element has been
identified in this extension as confined in the three hexamers 14, 15, and 16 and as consisting of AGP in the basic motif
5'-G79NNNNN-G85NNNNN-G91NNNNN-3'.
In fact, the experiments demonstrated the requirement for three G's
interspaced with 5 nt, so that the motif could end at nt 91 with
G91, the most remote feature, which is absolutely required.
In retrospect, the H4-
DRA/GP and H4-
DRA/AGP RNAs containing 90 nt
of the promoter linked to the DraIII site could have been
functional if the next nucleotide (nt 91) had been a G. In both cases,
however, the fusion with the DRA site inserted a C at this position,
confirming the detrimental effect of C91 as in
H4-
DRA/AGP-G91C (construct 2, Fig. 5B). The absence of the minimal
motif in the other derivatives of the same series that failed to
replicate was also confirmed in retrospect (data not shown). The
requirement for the presence of three interspaced G's appears
absolute, since any combination of only two remaining is nonfunctional.
Moreover, the position of the motif appears rigid, since displacement
by 6 nt toward the end is not permitted. It is the distance to the end
that is measured here.
Because of the identical requirement for a minimal length and the
presence of the same basic motif, it is likely that these features are
also those of GP. A previous study of GP examined the consequence of
insertions of one, two, or three hexamers between nt 47 and 67. Under
conditions which corresponded to those of the experiments presented
here, these insertions, including that of a single hexamer, were not
permitted (43). In view of the present results, it is likely
that the insertions eliminated replication by causing inward
displacement of the motif. Together, these results argue for a
requirement for the exact positioning of the motif, which cannot be
displaced by one hexamer to either side.
By image reconstruction of negatively stained electron micrographs, the
SeV nucleocapsid has been described as a left-handed helix counting 13 N subunits per turn, with each subunit predicted to contact 6 nt
(16), a prediction which was later corroborated by discovery
of the rule of six (5). It may be significant that in this
structure, the three hexamers, 14, 15, and 16, are positioned on the
same face of the helix, exactly stacked above hexamers 1, 2, and 3, a
stacking that cannot be skewed in either direction by addition or
deletion of one hexamer. In this way, the first three hexamers are in
proximity to the second element, although they are separated by 79 nt.
This spatial arrangement suggests that the two elements are seen by the
same surface of the replicating complex, although in the absence of any
structural information, such considerations should remain speculative.
The first promoter element (nt 1 to 31) was functionally defined as
containing, by itself, a signal regulating the efficiency of
replication (6, 44). Whether the different replication efficiency reflects a different binding affinity for the RNA polymerase is not known. A difference in elongation efficiency following the entry
of an identical RNA polymerase has to be envisaged as well. Since
elongation is a step proposed to depend on the rate of nascent chain
encapsidation (25, 26, 46), encapsidation initiation can
also control replication efficiency. This complex and still unresolved
mechanism of control of replication leaves ample space for a role for
the second promoter element identified in the present study. The higher
replication efficiency of H4-AGP(+)57 RNA than of H4-
DRA/GP RNA
(Fig. 3), two RNAs which differ in the second element, suggests that
the one on AGP can be functionally different from the one on GP. This
second element could then constitute the feature previously identified
in AGP as exerting a positive effect on replication, a minor effect
compared to that of the nt 1 to 30 element and apparent only in the
absence of this latter [as in H4-AGP(+)57 RNA
(44)]. This interpretation is not immediately consistent with the definition of the nt 79 to 91 element as being (GNNNNN)3, a basic motif identical in GP and AGP. It is
noteworthy, however, that the experiments performed to define this
motif selected for the ability to replicate but not for the ability to
differentially replicate.
The motif (GNNNNN)3 in a nucleocapsid structure where each
N subunit is predicted to contact 6 nt is reminiscent of the motif (GNN)6 found in tobacco mosaic virus, a rodlike virus where
each coat protein subunit contacts three nucleotides. This
trinucleotide motif of tobacco mosaic virus constitutes the site of the
initiation of virus assembly (45), and the definition of the
structure of TMV at atomic resolution (34) has provided
insight into the mechanism of this assembly. When a G is present in
position 1 of the trinucleotide, it can form two additional hydrogen
bonds to the coat protein, a feature that makes the presence of G at this position particularly significant for the nucleation site of
assembly, where six GNN motifs are found. By analogy, it is tempting to
speculate that the three hexamers 14, 15, and 16 could represent the
nucleation site for SeV nucleocapsid assembly (a site postulated to be
within the first 12 to 18 nt, based on assembly experiments of the VSV
nucleocapsid [2, 3] before it was known
that the two viruses differ in the extent of promoter sequence). If
this were grounded, the initiation site for SeV encapsidation would be
located past the initiation site for the first transcription unit (nt
56). This could argue against the transcription-to-replication-switch model which postulates that the nascent RNA encapsidation is effective before the polymerase reaches the site where the switch must occur (25, 26). If the encapsidation site were past the
transcription initiation site, it would be difficult to explain how a
polymerase that cannot replicate due to too low an N protein content
could be switched into transcription. It is noteworthy in this respect that for respiratory syncytial virus, an increased N expression was
shown not to alter the balance between transcription and replication, although replication was stimulated (19), indicating that in this particular example the two processes were not linked.
The (GNNNNN)3 motif is located such that, for three times
in a row, the G is positioned as the first of the six nucleotides contacting the N protein (hexamer phase context 1). This may constitute another example of the importance of the hexamer phase in defining the
signals addressed to the RNA polymerase. An alignment analysis of the
motif present at the mRNA start site of nine paramyxoviruses (for which
the total number of nucleotides is a multiple of 6) showed a remarkable
degree of conservation of the phase context with a significant
preference for starting at hexamer positions 1 and 2 (28).
The conservation of the phase was also noticed for the motif involved
in the P gene mRNA editing, a AnGn purine run which directs a number of
G insertions in the P mRNA provoking a frameshift to access an internal
ORF (V ORF [reviewed in reference 27]). Since the
number of G insertions varies among different virus groups to mirror
their requirements to switch between the in-frame and out-of-frame
ORFs, it is particularly significant that the conservation is the
strongest in each virus group (28). When the GP and AGP of
the nine paramyxoviruses are aligned, a strong conservation of the
(GNNNNN)3 in hexamers 14, 15, and 16 is again apparent. Of
17 promoters, 11 contain the motif at the right position, a number that
increases to 14 of 17 if A, the other purine, is tolerated in place of
G in one or two hexamers (Fig. 9).
Computation of the frequency with which a particular nucleotide
occupies the first position in the first 17 hexamers of the promoters
for which the viral RNA is a multiple of 6 nt highlights the
significant higher representation of G for hexamers 14, 15, and 16 (Fig. 10). It is noteworthy at this
point that an insertion of 18 nt in the middle of the GP motif (at nt
80), unexpectedly re-creating a (GNNNNN)3 motif but shifted
by 1 nt toward the end, so that the G's are now in hexamer position 6 (G6 NNNNNG6 NNNNNG6 N), failed to
yield a viable recombinant SeV (21), in contrast to a 18-nt
insertion at nt 119. This could suggest that a change of one position
in the phase context is not permitted, although in changing the phase,
the distance to the end (to the first element) is similarly affected,
so that the two parameters are concomitantly affected.

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 9.
Prevalence of (GNNNNN)3 among
paramyxoviruses. The GP and AGP sequences (as positive-strand DNA from
5' to 3') of nine paramyxoviruses are aligned to emphasize the sequence
similarity in the three hexamers under focus here. SeV, BPIV3 (bovine
parainfluenza type 3), and HPIV3 (human parainfluenza type 3) are
closely related in the SeV subgroup. MEAS (measles virus), RIND
(rinderpest virus), and DOLPHIN belong to the subgroup of the
morbilliviruses. MUMPS, SV41, and SV5 (simian virus 41 and 5) belong to
the subgroup of the rubulaviruses. The AGP sequence of the dolphin
morbillivirus is not available.
|
|

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 10.
Frequency of the presence of each nucleotide in the
first hexamer position. The frequency with which a particular
nucleotide is found in the first hexamer position is plotted as a
function of the hexamer number in the GP and AGP of the SeV and
morbillivirus subgroups (Fig. 9), which are known to contain a viral
RNA with the total number of nucleotides being a 6n + 0 number.
|
|
In conclusion, a clear demonstration of the minimal promoter length is
provided with the confirmation that both GP and AGP extend past the
leader template regions. A basic motif of (GNNNNN)3 with a
necessary positioning in hexamers 14, 15, and 16 with respect to the
end and with, most probably, a necessary hexamer phase context of 1 has
been defined. This constitutes the second element of SeV promoters.
Whether another sequence between these two elements (in nt 31 to 78)
participates in the replication promoter definition is open to
question. An H4-(+)
Dra/AGP96 derivative with all the nucleotides
between nt 32 and 78 turned into their complements failed to replicate
(preliminary data [not shown]). Whether this failure argues for the
presence of still another element in between the two described or
results in the insertion of a poisoned sequence is under investigation
through selection experiments of the kind presented here.
 |
ACKNOWLEDGMENTS |
We are indebted to Stephane Hausmann and Dominique Garcin for
discussions and technical advice (to C.T.) and to Nathalie
Fouillot-Coriou for general supervision of D.M. L.R. thanks Dave
Rowlands for editing of the manuscript and for his efforts to put it in
Shakespearean language.
This work was supported by a grant from the Swiss National Foundation
for Scientific Research.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Genetics and Microbiology, University of Geneva Medical School, CMU, 9 ave. de Champel, 1211 Geneva 4, Switzerland. Phone: 41-22-702-56-83. Fax: 41-22-702-57-02. E-mail:
Laurent.Roux{at}medecine.unige.ch.
 |
REFERENCES |
| 1.
|
Blumberg, B. M.,
J. Chan, and S. A. Udem.
1991.
Function of paramyxovirus 3' and 5' end sequences in theory and practice, p. 235-247. In
D. W. Kingsbury (ed.), The paramyxoviruses.
Plenum Publishing Corp., New York, N.Y.
|
| 2.
|
Blumberg, B. M.,
C. Giorgi, and D. Kolakofsky.
1983.
N protein of vesicular stomatitis virus selectively encapsidates leader RNA in vitro.
Cell
32:559-567[Medline].
|
| 3.
|
Blumberg, B. M.,
M. Leppert, and D. Kolakofsky.
1981.
Interaction of VSV leader RNA and nucleocapsid protein may control VSV genome replication.
Cell
23:837-845[Medline].
|
| 4.
|
Calain, P.,
J. Curran,
D. Kolakofsky, and L. Roux.
1992.
Molecular cloning of natural paramyxovirus copy-back defective interfering RNAs and their expression from DNA.
Virology
191:62-71[Medline].
|
| 5.
|
Calain, P., and L. Roux.
1993.
The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA.
J. Virol.
67:4822-4830[Abstract/Free Full Text].
|
| 6.
|
Calain, P., and L. Roux.
1995.
Functional characterisation of the genomic and antigenomic promoter of the Sendai virus.
Virology
211:163-173.
|
| 7.
|
Collins, P. L.,
M. A. Mink,
M. G. Hill III,
E. Camargo,
H. Grosfeld, and D. S. Stec.
1993.
Rescue of a 7502-nucleotide (49.3% of full-length) synthetic analog of respiratory syncytial virus genomic RNA.
Virology
195:252-256[Medline].
|
| 8.
|
Collins, P. L.,
M. A. Mink, and D. S. Stec.
1991.
Rescue of synthetic analogs of respiratory syncytial genomic RNA and effect of truncations and mutations on the expression of a foreign reporter gene.
Proc. Natl. Acad. Sci. USA
88:9663-9667[Abstract/Free Full Text].
|
| 9.
|
Conzelmann, K.-K.
1996.
Genetic manipulation of non-segmented negative-strand RNA viruses.
J. Gen. Virol.
77:381-389[Abstract/Free Full Text].
|
| 10.
|
Crowley, J. C.,
P. C. Dowling,
J. Menonna,
J. I. Sliverman,
D. Schuback,
S. D. Cook, and B. M. Blumberg.
1988.
Sequence variability and function of measles virus 3' and 5' ends and intercistronic regions.
Virology
164:498-506[Medline].
|
| 11.
|
Curran, J.,
R. Boeck, and D. Kolakofsky.
1991.
The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing.
EMBO J.
10:3079-3085[Medline].
|
| 12.
|
Curran, J., and D. Kolakofsky.
1989.
Scanning independant ribosomal initiation of the Sendai virus Y proteins in vitro and in vivo.
EMBO J.
8:521-526[Medline].
|
| 13.
|
Curran, J., and D. Kolakofsky.
1990.
Sendai virus P gene produces multiple proteins from overlapping open reading frames.
Enzyme
44:244-249[Medline].
|
| 14.
|
Curran, J.,
J.-B. Marq, and D. Kolakofsky.
1992.
The Sendai virus nonstructural C proteins specifically inhibit viral mRNA synthesis.
Virology
189:647-656[Medline].
|
| 15.
|
Dimock, K., and P. L. Collins.
1993.
Rescue of synthetic analogs of genomic RNA and replicative-intermediate RNA of human parainfluenza virus type 3.
J. Virol.
67:2772-2778[Abstract/Free Full Text].
|
| 16.
|
Egelman, E. H.,
S.-S. Wu,
M. Amrein,
A. Portner, and G. Murti.
1989.
The Sendai virus nucleocapsid exists in at least four different helical states.
J. Virol.
63:2233-2243[Abstract/Free Full Text].
|
| 17.
|
Enami, M.,
T. Kohama, and A. Sugiura.
1989.
A measles virus subgenomic RNA: structure and generation mechanism.
Virology
171:427-433[Medline].
|
| 18.
|
Engelhorn, M.,
R. Stricker, and L. Roux.
1993.
Molecular cloning and characterization of a Sendai virus internal deletion defective RNA.
J. Gen. Virol.
74:137-141[Abstract/Free Full Text].
|
| 19.
|
Fearns, R.,
M. E. Peeples, and P. L. Collins.
1997.
Increased expression of the N protein of respiratory syncytial virus stimulates minigenome replication but does not alter the balance between the synthesis of mRNA and antigenome.
Virology
236:188-201[Medline].
|
| 20.
|
Fuerst, T. R.,
E. G. Niles,
F. W. Studier, and B. Moss.
1986.
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
Proc. Natl. Acad. Sci. USA
83:8122-8126[Abstract/Free Full Text].
|
| 21.
|
Hasan, M. K.,
A. Kato,
T. Shioda,
Y. Sakai,
D. Yu, and Y. Nagai.
1997.
Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3' proximal first locus.
J. Gen. Virol.
78:2813-2820[Abstract].
|
| 22.
|
Holland, J. J.
1987.
Defective interfering rhabdoviruses, p. 297-360. In
R. R. Wagner (ed.), The rhabdoviruses.
Plenum Publishing Corp., New York, N.Y.
|
| 23.
|
Kast, W. M.,
L. Roux,
J. Curran,
H. J. J. Blom,
A. C. Voordouw,
R. H. Meloen,
D. Kolakofsky, and C. J. M. Melief.
1991.
Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide.
Proc. Natl. Acad. Sci. USA
88:2283-2287[Abstract/Free Full Text].
|
| 24.
|
Keene, J. D.,
I. M. Chien, and R. A. Lazzarini.
1981.
Vesicular stomatitis defective interfering particle containing a mutated, internal leader RNA gene.
Proc. Natl. Acad. Sci. USA
78:2090-2094[Abstract/Free Full Text].
|
| 25.
|
Kingsbury, D. W.
1974.
The molecular biology of paramyxoviruses.
Med. Microbiol. Immunol.
160:73-83[Medline].
|
| 26.
|
Kolakofsky, D., and B. M. Blumberg.
1982.
A model for the control of non-segmented negative strand virus genome replication, p. 203-213. In
B. W. J. Mahy, A. C. Minson, and G. K. Darby (ed.), Virus persistence.
Cambridge University Press, Cambridge, United Kingdom.
|
| 27.
|
Kolakofsky, D.,
J. Curran,
T. Pelet, and J. P. Jacques.
1993.
Paramyxovirus P gene mRNA editing, chapter 5, p. 1-21. In
R. Benne (ed.), RNA editing.
Ellis Horwood, Chichester, United Kingdom.
|
| 28.
|
Kolakofsky, D.,
T. Pelet,
D. Garcin,
S. Hausmann,
J. Curran, and L. Roux.
1998.
Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited.
J. Virol.
72:891-899[Free Full Text].
|
| 29.
|
Kolakofsky, D.,
S. Vidal, and J. Curran.
1991.
Paramyxovirus RNA synthesis and P gene expression, p. 215-233. In
D. W. Kingsbury (ed.), The paramyxoviruses.
Plenum Publishing Corp., New York, N.Y.
|
| 30.
|
Lamb, R. A., and D. Kolakofsky.
1996.
Paramyxoviridae: the viruses and their replication, p. 1177-1204. In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology.
Lippincott-Raven, Philadelphia, Pa.
|
| 31.
|
Leppert, M.,
L. Kort, and D. Kolakofsky.
1977.
Further characterization of Sendai virus DI-RNAs: a model for their generation.
Cell
12:539-552[Medline].
|
| 32.
|
Li, T., and A. K. Pattnaik.
1997.
Replication signals in the genome of vesicular stomatitis virus and its defective interfering particles: indentification of a sequence element that enhances DI RNA replication.
Virology
232:248-259[Medline].
|
| 33.
|
Mottet, G.,
A. Mühlemann,
C. Tapparel,
F. Hoffmann, and L. Roux.
1996.
A Sendai virus vector leading to the efficient expression of mutant M proteins interfering with virus particle budding.
Virology
221:159-171[Medline].
|
| 34.
|
Namba, K.,
R. Pattanayek, and G. Stubbs.
1989.
Visualization of protein-nucleic-acid interactions in a virus. Refined structure of intact tobacco mosaic virus at 2.9 A resolution by X-ray fiber diffraction.
J. Mol. Biol.
208:307-325[Medline].
|
| 35.
|
Neubert, W. J.,
C. Eckerskorn, and H. E. Homann.
1991.
Sendai virus NP gene codes for a 524 amino acid NP protein.
Virus Genes
5:25-32[Medline].
|
| 36.
|
Pelet, T.,
C. Delenda,
O. Gubbay,
D. Garcin, and D. Kolakofsky.
1996.
Partial characterization of a Sendai virus replication promoter and the rule of six.
Virology
224:405-414[Medline].
|
| 37.
|
Re, G. G.
1991.
Deletion mutants of paramyxoviruses, p. 275-298. In
D. W. Kingsbury (ed.), The paramyxoviruses.
Plenum Publishing Corp., New York, N.Y.
|
| 38.
|
Schubert, M.,
J. D. Keen, and R. A. Lazzarini.
1979.
A specific internal RNA polymerase recognition site of VSV RNA is involved in the generation of DI particles.
Cell
18:749-757[Medline].
|
| 39.
|
Shioda, T.,
Y. Hidaka,
T. Kanda,
H. Shibuta,
A. Nomoto, and K. Iwasaki.
1983.
Sequence of 3'687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins.
Nucleic Acids Res.
11:7317-7330[Abstract/Free Full Text].
|
| 40.
|
Shioda, T.,
K. Iwasaki, and H. Shibuta.
1986.
Determination of the complete nucleotide sequence of the Sendai virus genome RNA and the predicted amino acid sequences of the F, HN, and L proteins.
Nucleic Acids Res.
14:1545-1563[Abstract/Free Full Text].
|
| 41.
|
Sidhu, M. S.,
J. Crowley,
A. Lowenthal,
D. Karcher,
J. Mennona,
S. Cook,
S. A. Udem, and P. Dowling.
1994.
Defective measles virus in human subacute sclerosing panencephalitis brain.
Virology
202:631-641[Medline].
|
| 42.
|
Sidhu, M. S.,
K. Kaelin,
P. Spielhofer,
F. Radecke,
H. Schneider,
M. Masurekar,
P. C. Dowling,
M. A. Billeter, and S. A. Udem.
1995.
Rescue of a synthetic measles virus minireplicons: measles genomic termini direct efficient expression and propagation of a reporter gene.
Virology
208:800-807[Medline].
|
| 43.
|
Tapparel, C.,
S. Hausmann,
T. Pelet,
J. Curran,
D. Kolakofsky, and L. Roux.
1997.
Inhibition of Sendai virus genome replication due to promoter increased selectivity: a possible role for the accessory C proteins.
J. Virol.
71:9588-9599[Abstract].
|
| 44.
|
Tapparel, C., and L. Roux.
1996.
The efficiency of Sendai virus genome replication: the importance of the RNA primary sequence independent of terminal complementarity.
Virology
225:163-171[Medline].
|
| 45.
|
Turner, D. R.,
L. E. Joyce, and P. J. Butler.
1988.
The tobacco mosaic virus assembly origin RNA: functional characteristics defined by direct mutagenesis.
J. Mol. Biol.
203:531-547[Medline].
|
| 46.
|
Vidal, S., and D. Kolakofsky.
1989.
Modified model for the switch from Sendai virus transcription to replication.
J. Virol.
63:1951-1958[Abstract/Free Full Text].
|
| 47.
|
Wertz, G. W.,
S. Whelan,
A. LeGrone, and L. A. Ball.
1994.
Extent of terminal complementarity modulates the balance between transcription and replication of vesicular stomatitis virus RNA.
Proc. Natl. Acad. Sci. USA
91:8587-8591[Abstract/Free Full Text].
|
| 48.
|
Yu, Q.,
R. Hardy, and G. W. Wertz.
1995.
Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication.
J. Virol.
69:2412-2419[Abstract].
|
J Virol, April 1998, p. 3117-3128, Vol. 72, No. 4
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Enterlein, S., Schmidt, K. M., Schumann, M., Conrad, D., Krahling, V., Olejnik, J., Muhlberger, E.
(2009). The Marburg Virus 3' Noncoding Region Structurally and Functionally Differs from That of Ebola Virus. J. Virol.
83: 4508-4519
[Abstract]
[Full Text]
-
Rennick, L. J., Duprex, W. P., Rima, B. K.
(2007). Measles virus minigenomes encoding two autofluorescent proteins reveal cell-to-cell variation in reporter expression dependent on viral sequences between the transcription units. J. Gen. Virol.
88: 2710-2718
[Abstract]
[Full Text]
-
Walpita, P., Peters, C. J.
(2007). Cis-acting elements in the antigenomic promoter of Nipah virus. J. Gen. Virol.
88: 2542-2551
[Abstract]
[Full Text]
-
Cordey, S., Roux, L.
(2007). Further characterization of a paramyxovirus transcription initiation signal: search for required nucleotides upstream and importance of the N phase context. J. Gen. Virol.
88: 1555-1564
[Abstract]
[Full Text]
-
Cowton, V. M., McGivern, D. R., Fearns, R.
(2006). Unravelling the complexities of respiratory syncytial virus RNA synthesis. J. Gen. Virol.
87: 1805-1821
[Abstract]
[Full Text]
-
Hoffman, M. A., Thorson, L. M., Vickman, J. E., Anderson, J. S., May, N. A., Schweitzer, M. N.
(2006). Roles of human parainfluenza virus type 3 bases 13 to 78 in replication and transcription: identification of an additional replication promoter element and evidence for internal transcription initiation.. J. Virol.
80: 5388-5396
[Abstract]
[Full Text]
-
Cordey, S., Roux, L.
(2006). Transcribing paramyxovirus RNA polymerase engages the template at its 3' extremity.. J. Gen. Virol.
87: 665-672
[Abstract]
[Full Text]
-
Cowton, V. M., Fearns, R.
(2005). Evidence that the Respiratory Syncytial Virus Polymerase Is Recruited to Nucleotides 1 to 11 at the 3' End of the Nucleocapsid and Can Scan To Access Internal Signals. J. Virol.
79: 11311-11322
[Abstract]
[Full Text]
-
Weik, M., Enterlein, S., Schlenz, K., Muhlberger, E.
(2005). The Ebola Virus Genomic Replication Promoter Is Bipartite and Follows the Rule of Six. J. Virol.
79: 10660-10671
[Abstract]
[Full Text]
-
Kolakofsky, D., Roux, L., Garcin, D., Ruigrok, R. W. H.
(2005). Paramyxovirus mRNA editing, the 'rule of six' and error catastrophe: a hypothesis. J. Gen. Virol.
86: 1869-1877
[Abstract]
[Full Text]
-
Banyard, A. C., Baron, M. D., Barrett, T.
(2005). A role for virus promoters in determining the pathogenesis of Rinderpest virus in cattle. J. Gen. Virol.
86: 1083-1092
[Abstract]
[Full Text]
-
McGivern, D. R., Collins, P. L., Fearns, R.
(2005). Identification of Internal Sequences in the 3' Leader Region of Human Respiratory Syncytial Virus That Enhance Transcription and Confer Replication Processivity. J. Virol.
79: 2449-2460
[Abstract]
[Full Text]
-
Vulliemoz, D., Cordey, S., Mottet-Osman, G., Roux, L.
(2005). Nature of a paramyxovirus replication promoter influences a nearby transcription signal. J. Gen. Virol.
86: 171-180
[Abstract]
[Full Text]
-
Le Mercier, P., Garcin, D., Garcia, E., Kolakofsky, D.
(2003). Competition between the Sendai Virus N mRNA Start Site and the Genome 3'-End Promoter for Viral RNA Polymerase. J. Virol.
77: 9147-9155
[Abstract]
[Full Text]
-
Neumann, G., Whitt, M. A., Kawaoka, Y.
(2002). A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?. J. Gen. Virol.
83: 2635-2662
[Abstract]
[Full Text]
-
Bhella, D., Ralph, A., Murphy, L. B., Yeo, R. P.
(2002). Significant differences in nucleocapsid morphology within the Paramyxoviridae. J. Gen. Virol.
83: 1831-1839
[Abstract]
[Full Text]
-
Vulliemoz, D., Roux, L.
(2002). Given the Opportunity, the Sendai Virus RNA-Dependent RNA Polymerase Could as Well Enter Its Template Internally. J. Virol.
76: 7987-7995
[Abstract]
[Full Text]
-
Le Mercier, P., Garcin, D., Hausmann, S., Kolakofsky, D.
(2002). Ambisense Sendai Viruses Are Inherently Unstable but Are Useful To Study Viral RNA Synthesis. J. Virol.
76: 5492-5502
[Abstract]
[Full Text]
-
Schmidt, A. C., Wenzke, D. R., McAuliffe, J. M., St. Claire, M., Elkins, W. R., Murphy, B. R., Collins, P. L.
(2002). Mucosal Immunization of Rhesus Monkeys against Respiratory Syncytial Virus Subgroups A and B and Human Parainfluenza Virus Type 3 by Using a Live cDNA-Derived Vaccine Based on a Host Range-Attenuated Bovine Parainfluenza Virus Type 3 Vector Backbone. J. Virol.
76: 1089-1099
[Abstract]
[Full Text]
-
Mioulet, V., Barrett, T., Baron, M. D.
(2001). Scanning mutagenesis identifies critical residues in the rinderpest virus genome promoter. J. Gen. Virol.
82: 2905-2911
[Abstract]
[Full Text]
-
Vulliémoz, D., Roux, L.
(2001). "Rule of Six": How Does the Sendai Virus RNA Polymerase Keep Count?. J. Virol.
75: 4506-4518
[Abstract]
[Full Text]
-
Schmidt, A. C., McAuliffe, J. M., Murphy, B. R., Collins, P. L.
(2001). Recombinant Bovine/Human Parainfluenza Virus Type 3 (B/HPIV3) Expressing the Respiratory Syncytial Virus (RSV) G and F Proteins Can Be Used To Achieve Simultaneous Mucosal Immunization against RSV and HPIV3. J. Virol.
75: 4594-4603
[Abstract]
[Full Text]
-
Coronel, E. C., Takimoto, T., Murti, K. G., Varich, N., Portner, A.
(2001). Nucleocapsid Incorporation into Parainfluenza Virus Is Regulated by Specific Interaction with Matrix Protein. J. Virol.
75: 1117-1123
[Abstract]
[Full Text]
-
Parks, C. L., Lerch, R. A., Walpita, P., Wang, H.-P., Sidhu, M. S., Udem, S. A.
(2001). Analysis of the Noncoding Regions of Measles Virus Strains in the Edmonston Vaccine Lineage. J. Virol.
75: 921-933
[Abstract]
[Full Text]
-
Fearns, R., Collins, P. L., Peeples, M. E.
(2000). Functional Analysis of the Genomic and Antigenomic Promoters of Human Respiratory Syncytial Virus. J. Virol.
74: 6006-6014
[Abstract]
[Full Text]
-
Choudhary, S., De, B. P., Banerjee, A. K.
(2000). Specific Phosphorylated Forms of Glyceraldehyde 3-Phosphate Dehydrogenase Associate with Human Parainfluenza Virus Type 3 and Inhibit Viral Transcription In Vitro. J. Virol.
74: 3634-3641
[Abstract]
[Full Text]
-
Stillman, E. A., Whitt, M. A.
(1999). Transcript Initiation and 5'-End Modifications Are Separable Events during Vesicular Stomatitis Virus Transcription. J. Virol.
73: 7199-7209
[Abstract]
[Full Text]
-
Finke, S., Conzelmann, K.-K.
(1999). Virus Promoters Determine Interference by Defective RNAs: Selective Amplification of Mini-RNA Vectors and Rescue from cDNA by a 3' Copy-Back Ambisense Rabies Virus. J. Virol.
73: 3818-3825
[Abstract]
[Full Text]
-
Whelan, S. P. J., Wertz, G. W.
(1999). Regulation of RNA Synthesis by the Genomic Termini of Vesicular Stomatitis Virus: Identification of Distinct Sequences Essential for Transcription but Not Replication. J. Virol.
73: 297-306
[Abstract]
[Full Text]
-
Murphy, S. K., Parks, G. D.
(1999). RNA Replication for the Paramyxovirus Simian Virus 5 Requires an Internal Repeated (CGNNNN) Sequence Motif. J. Virol.
73: 805-809
[Abstract]
[Full Text]